Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis
European Journal of Neurology · 2023
DOI: 10.1111/ene.15823 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Anna J Pedrosa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Medical Ethics, Philipps-University Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Tremor is often perceived as severely disabling by patients with idiopathic Parkinson's disease (iPD) and yet ranges among the most difficult symptoms to treat. To date, no comprehensive analysis of non‐lesional therapies to manage tremor in iPD exists to base recommendations upon. We therefore present a systematic literature review and meta‐analysis assessing the efficacy/effectiveness and safety of non‐lesional treatments for tremor in iPD.
Methods
Three electronic databases were searched using a combination of title/abstract keywords complemented by hand‐searching of reference lists. A random‐effects meta‐analysis of standardized mean change scores was conducted where appropriate.
Results
Some 114 studies met inclusion criteria involving 8045 patients. The meta‐analysis revealed an overall reduction of standardized mean change scores by (−0.93 [CI: −1.42; −0.43], p < 0.001) by 14 different dopaminergic and non‐dopaminergic classes of agents. No significant differences were identified between direct comparisons. Subgroup analysis comparing dopamine receptor agonists resulted in superior effects of pramipexole and rotigotine compared with ropinirole. There was little cumulative evidence to support the use of individual non‐pharmacological interventions for tremor, except for electrical stimulation.
Conclusions
The results of this meta‐analysis suggest a large but nonspecific effect of established pharmacological therapies on tremor in iPD. Based on high‐quality studies, there is sufficient evidence to support that levodopa, dopamine receptor agonists, and monoamine oxidase inhibitors provide tremor relief in most patients, while evidence supporting other treatments is less well established. Sufficient evidence to draw conclusions on effects of non‐lesional treatments in cases with refractory tremor is lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Group Medical Ethics, Philipps-University Marburg, Marburg, Germany.
- Department of Neurology, University Hospital Gießen and Marburg, Marburg, Germany.
- Centre for Mind, Brain and Behaviour, Philipps-University Marburg, Marburg, Germany.
ORCID-Profile: Anna J Pedrosa, Josefine Waldthaler, Lars Timmermann, David J Pedrosa
Zitieren
APA
Pedrosa, A. J., Waldthaler, J., Mügge, F., Timmermann, L., & Pedrosa, D. J. (2023). Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis. European Journal of Neurology. https://doi.org/10.1111/ene.15823
Vancouver
Pedrosa AJ, Waldthaler J, Mügge F, Timmermann L, Pedrosa DJ. Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis. European Journal of Neurology. 2023. doi:10.1111/ene.15823
BibTeX
@article{Pedrosa2023,
author = {Pedrosa, Anna J and Waldthaler, Josefine and Mügge, Felicitas and Timmermann, Lars and Pedrosa, David J},
title = {Non‐lesional treatments for tremor in Parkinson's disease: A systematic review and meta‐analysis},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15823}
}
EUVIMED